‘Medicare for all’ on minds of Democrats as Sanders launches second White House bid; Supreme Court rejects Maryland price-gouging law appeal; Hugin joins Allergan board.
Five things for pharma marketers to know: Tuesday, February 12, 2019
Sanders wants answers from Catalyst about price hike; Obesity-related cancers on the rise among young; Experts call for global distribution of drug preventing cervical cancer.
Five things for pharma marketers to know: Tuesday, January 29, 2019
J&J beats Q4 expectations, warns of sales slowdown; Behind the scenes of Lilly’s drug pricing ad decision; Cost of diabetes treatments doubled in five years.
Five things for pharma marketers to know: Tuesday, January 15, 2019